Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ANPEP | P15144 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | PGK1 | P00558 | 1/20 | 0.30 |
| ▸ | PGK2 | P07205 | 1/20 | 0.30 |
| ▸ | TLR2 | O60603 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23988533 | 0.87 | LPAR5 (0.36) | LPAR5KDM4E | |
| SCHEMBL15218995 | 0.86 | KDM4E (0.41) | KDM4E | |
| SCHEMBL19660807 | 0.85 | KDM4E (0.40) | KDM4E | |
| SCHEMBL15218991 | 0.85 | KDM4E (0.40) | KDM4E | |
| SCHEMBL15218975 | 0.83 | KDM4E (0.39) | LPAR5KDM4E | |
| SCHEMBL29313966 | 0.82 | LPAR5 (0.50) | LPAR5KDM4EANPEPCYP3A4 | |
| SCHEMBL9927953 | 0.82 | KDM4E (0.38) | KDM4EANPEPCYP3A4TLR2 | |
| SCHEMBL16298540 | 0.81 | KDM4E (0.44) | LPAR5KDM4ECYP3A4CYP2D6 | |
| SCHEMBL29321208 | 0.81 | KDM4E (0.37) | LPAR5KDM4ECYP3A4CYP2D6 | |
| SCHEMBL23988623 | 0.81 | LPAR5 (0.34) | LPAR5KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210340404-A1 | SILANOL COMPOSITIONS AND METHODS OF USE | 3M INNOVATIVE PROPERTIES COMPANY | 2021-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210340404-A1 | SILANOL COMPOSITIONS AND METHODS OF USE | EPCAM, ITGA8, CD99 | LPAR5 3116/4885KDM4E 985/4885ANPEP 635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.